logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hainan Ruizhe: Deputy General Manager Yu Qingchi intends to reduce his holdings by no more than 0.02%.

date
12/11/2025
Hainan Ruizhe announcement: The company's deputy general manager Yu Qingchi holds 924,000 shares, accounting for 0.08% of the total share capital. He plans to reduce his holdings by no more than 231,000 shares, accounting for 0.02% of the total share capital, through centralized bidding from December 4, 2025 to March 3, 2026, representing 25% of his holdings.
Latest
3 m ago
The price of gold is making a big comeback, waiting to break out. How to achieve the "doubling" returns only possible with leverage? The answer is to bet on gold stocks.
4 m ago
The lawsuit filed by Tianqi Lithium's (002466.SZ) subsidiary, Tianqi Chile, was dismissed by the Chilean court.
7 m ago
Stratus Properties (STRS.US): The third quarter financial report for 2025 achieved revenue of 4.969 million US dollars, down from 8.891 million US dollars; earnings per share were -0.62 US dollars, down from -0.05 US dollars.
7 m ago
Ha Hanhua Tong: Shareholder Changzhou Xiehe reduces its shareholding by 0.50%
7 m ago
Atossa Therapeutics (ATOS.US): In the third quarter of 2025, the revenue of 0 US dollars was achieved, the previous value was 0 US dollars; earnings per share was -0.07 US dollars, the previous value was -0.06 US dollars, and the expected value was -0.07 US dollars.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.